Clinical Trial

A Study Of Stellate Ganglion Blockade With Liposomal Bupivacaine In Preventing Atrial Fibrillation After Isolated Coronary Artery Bypass Grafting Surgery

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The purpose of this study is assess the incidence of postoperative atrial fibrillation (POAF) within one week of surgery in patients who receive pre-surgical stellate ganglion blockade with liposomal bupivacaine, compared to those receiving a saline placebo, using continuous electrocardiographic monitoring via wearable ECG devices.
Trial Details
NCT Number NCT07570940
Lead Sponsor Mayo Clinic
Conditions Coronary Artery Disease, Atrial Fibrillation
Enrollment 450 participants
Start Date 2026-06
Primary Completion 2030-06 (estimated)
Study Completion 2030-06 (estimated)
Updated on ClinicalTrials.gov 2026-05-06